SLC1A2 and epilepsy: DHEA treatment resulted in a significant increase of EAAT2, EAAT1, and EAAT3 mRNA of glutamate transporters, indicating that DHEA treatment can induce the up‐regulation of these transporters, thus inhibiting the occurrence and development of epilepsy after brain injury.128